The Motley Fool

UK dividends collapse by half in the third quarter, but not at these two FTSE 100 giants!

Image source: Getty Images.

There are two great joys to being a long-term shareholder in companies. The first is the capital gains (profits) made by selling shares at higher prices than one paid for them. The second is the passive income one collects from firms that pay regular cash dividends to shareholders.

Dividends die in the third quarter

Now for awful news for dividend-loving shareholders and value investors. In the third quarter of 2020, the dividends paid by UK-listed companies almost halved, collapsing by 49.1% to just £18bn. This is the biggest plunge in Q3 payouts since 2020, according to this report from Link Asset Services.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

According to Link, two-thirds of companies listed in London cut, cancelled, or suspended their dividend payouts for the summer season. Clearly, given the economic ravages of the coronavirus, British companies decided to conserve cash. Instead of doling it out to shareholders, they elected to keep cash on their balance sheets to help ride out the downturn.

In Q2, payouts collapsed by 57% to £16.1bn, so at least the third quarter improved on the second. For 2020 as a whole, Link expects total dividends to dive by almost two-thirds (39%). This massive shortfall (estimated at £60bn) is a brutal blow for pensioners and investment funds at a time of ultra-low interest rates. In effect, UK dividends have rewound eight years, back to 2012.

This FTSE 100 firm pays 6% a year in cash

To bank steady dividends today, investors need to exercise caution. For me, the most reliable payouts come from big business leaders: powerful companies with strong balance sheets, revenues, and cash flows. Take, for example, GlaxoSmithKline (LSE: GSK), one of my favourite British businesses.

Before the coronavirus devastated economies and markets, GSK shares were flying high. They hit a 52-week peak of 1,857p on 24 January, but plunged below 1,375p at the market trough on 23 March. The share price then rebounded above 1,742p by 13 May, but has since slumped. As I write, GSK shares hover below 1,340p, even lower than their March bottom.

The good news for buyers of GSK shares today is that they pay a monster dividend. It’s the fifth-largest by size in the FTSE 100, in fact. GSK’s quarterly dividends total 80p a share, for a current dividend yield of 6%. Even better, this dividend is solidly covered 1.64 times by GSK’s yearly earnings. This bumper passive income is why I own GSK shares today and have done for decades.

This is the second-largest dividend in the FTSE 100

British American Tobacco (LSE: BATS) is my second ‘dividend darling’. It’s a value share that I’ve written about repeatedly since the dark day of March. Obviously, as the #1 cigarette maker in the world, BATS is certainly not a stock for ethical investors. But it’s an enormous global business with loyal (and addicted) customers, huge revenues, and strong cash flows.

As recent as 15 January, BATS shares hit a 52-week high of £35.07. Today, they trade almost £10 cheaper, after closing at £25.50. This makes BATS shares notably cheap, given their price-to-earnings ratio of 9.3 and earnings yield of 10.8%. What’s more, they offer a whopping dividend yield approaching 8.3%, covered 1.3 times by earnings.

In summary, as a value investor looking for income, I love the delightful dividends of GSK and BATS (which are at opposite ends of the healthcare system!). I’d happily buy both shares today inside an ISA so as to collect tax-free future dividends and capital gains.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.